Showing 1,001 - 1,020 results of 1,284 for search '(( significant decrease decrease ) OR ( significance ((level decrease) OR (mean decrease)) ))~', query time: 0.51s Refine Results
  1. 1001

    5.HT<sub>1A</sub> binding difference between known cause of death (KCOD) controls and SIDS. by Hannah C. Kinney (10280975)

    Published 2025
    “…When SIDS is compared to all KCOD controls, the HG, NTS, and MAO show a significant mean difference in 5-HT<sub>1A</sub> receptor binding. …”
  2. 1002

    Table 1_Health care resource use and costs associated with adult pneumococcal disease in the United States from 2017 to 2019, stratified by age and health risk: a retrospective coh... by Nicole Cossrow (473898)

    Published 2025
    “…</p>Conclusion<p>Targeting PD prevention efforts to high-risk groups based on age and/or health risk level could decrease the clinical and economic burden of adult PD in the US.…”
  3. 1003

    Data Sheet 1_Diagnostic utility of hematological and biochemical markers for cystic echinococcosis in Tibetan patients of Sichuan, China.pdf by Meng Ma (2075878)

    Published 2025
    “…Conversely, there was a decrease in lymphocyte percentage, hemoglobin concentration, mean corpuscular volume, and hematocrit. (2) Prothrombin time levels were markedly elevated beyond normal reference values, with prolonged prothrombin time identified as a significant predictor for CE. (3) The area under the receiver operating characteristic curve (AUC) for predicting CE based on prothrombin time was 0.969, while the AUC for predicting CE using a combination of prothrombin time and eosinophil percentage was 0.982.…”
  4. 1004

    Table 2_Cost-effectiveness of the 3E model in diabetes management: a machine learning approach to assess long-term economic impact.docx by Supriya Raghav (21412907)

    Published 2025
    “…</p>Results<p>The 3E model demonstrated significant cost reductions, with the intervention group achieving a 74.3% decrease in total costs compared to 41.8% in the control group while maintaining the same level of glycemic control. …”
  5. 1005

    Table 1_Cost-effectiveness of the 3E model in diabetes management: a machine learning approach to assess long-term economic impact.xlsx by Supriya Raghav (21412907)

    Published 2025
    “…</p>Results<p>The 3E model demonstrated significant cost reductions, with the intervention group achieving a 74.3% decrease in total costs compared to 41.8% in the control group while maintaining the same level of glycemic control. …”
  6. 1006

    Table 1_The effects of magnesium and vitamin D/E co-supplementation on inflammation markers and lipid metabolism of obese/overweight population: a systematic review and meta-analys... by Kai Deng (299054)

    Published 2025
    “…In contrast, the serum levels of interleukin-6 (IL-6) showed a non-significant decrease (MD: −0.09, 95%CI: −0.33, 0.15, p = 0.46), and did not significantly affect lipid metabolism according to levels of parameters such as serum triglyceride (MD = 1.84, 95% CI: −28.92, 32.60, p = 0.91), serum LDL-c (MD: −4.56, 95% CI: −14.19, 5.08, p = 0.35), and serum HDL-c (MD: 1.96, 95% CI: −3.07, 6.98, p = 0.45) in the co-supplementation of magnesium and Vitamin E.…”
  7. 1007

    Supplementary Material for: Preoperative prediction of microvascular invasion in intrahepatic cholangiocarcinoma and its prognostic implications: A multicenter study by figshare admin karger (2628495)

    Published 2025
    “…Stratifying patients by MVI risk—low (no predictors), intermediate (1–3 predictors), and high (4 predictors)— revealed a significant decrease in both recurrence-free and overall survival rates (p<0.001), along with a corresponding increase in early recurrence rates (p<0.001) as the risk level increased. …”
  8. 1008

    Effect of treatments on pH, conductivity, and biological oxygen demand (BOD) over time. by Khomsan Ruangrit (20833447)

    Published 2025
    “…Error bars represent standard deviations from the mean. Letters above the data points represent significant differences between treatments on the same day (Tukey’s HSD test, p <  0.05). …”
  9. 1009

    Supplementary Material for: Patients with Opioid Use Disorder Choosing Treatment with Extended-Release Naltrexone: A 6-Months Naturalistic Study by Brenna I.H. (19773549)

    Published 2024
    “…The majority of the MITT population (84; 60.9%) completed 24 weeks of treatment in the study. There was a significant decrease in the overall use of opioids (p<0.001) and the use of alcohol and other illicit substances was low. …”
  10. 1010

    Table 1_Phytotoxic effects of cigarette smoke on indoor plant Epipremnum aureum: in vivo analysis using chlorophyll a fluorescence transients.docx by Garishma Shah (21758924)

    Published 2025
    “…Key findings include a significant reduction in the mean surface area (MSA) of leaves. …”
  11. 1011

    Image1_The clinical and genetic aspects of six individuals with GH1 variants and isolated growth hormone deficiency type II.tif by Xiaozhen Huang (5858690)

    Published 2024
    “…Background<p>Isolated growth hormone deficiency type II (IGHD II) is an autosomal dominant disorder characterized by a GH1 gene variant resulting in a significant reduction in growth hormone (GH) secretion and a subsequent decrease of plasma insulin-like growth factor 1 (IGF-1) levels and eventual growth impairment.…”
  12. 1012

    Table1_The clinical and genetic aspects of six individuals with GH1 variants and isolated growth hormone deficiency type II.docx by Xiaozhen Huang (5858690)

    Published 2024
    “…Background<p>Isolated growth hormone deficiency type II (IGHD II) is an autosomal dominant disorder characterized by a GH1 gene variant resulting in a significant reduction in growth hormone (GH) secretion and a subsequent decrease of plasma insulin-like growth factor 1 (IGF-1) levels and eventual growth impairment.…”
  13. 1013

    The Impact of Mindfulness-Based Intervention on Reducing Aggressive Behaviour and Promoting Student Wellbeing in Sports by Moruf Adebayo Abidogun (13491958)

    Published 2025
    “…The results indicate a significant reduction in aggressive behaviour among the experimental group compared to the control group, with a marked decrease in verbal and physical aggression. …”
  14. 1014

    Table 2_Effect of dietary glycemic index on insulin resistance in adults without diabetes mellitus: a systematic review and meta-analysis.docx by Yu-Ting Yu (20717441)

    Published 2025
    “…<p>Low glycemic index (LoGI) diets are associated with decreased insulin resistance and are an effective strategy for patients with diabetes mellitus to control postprandial glucose levels. …”
  15. 1015

    Table 1_Effect of dietary glycemic index on insulin resistance in adults without diabetes mellitus: a systematic review and meta-analysis.docx by Yu-Ting Yu (20717441)

    Published 2025
    “…<p>Low glycemic index (LoGI) diets are associated with decreased insulin resistance and are an effective strategy for patients with diabetes mellitus to control postprandial glucose levels. …”
  16. 1016

    Table 1_Efficacy and safety of telitacicept in the treatment of IgA nephropathy: a single-center, real-world study.docx by Lin Tao (4236)

    Published 2025
    “…After 12 weeks and 24 weeks of treatment, patients in all three groups showed a significant decrease in 24 h proteinuria from baseline (P < 0.05). …”
  17. 1017

    CoA administration prevents ISC dysfunction through antioxidative ability and protects ISCs from stress-induced DNA damage. by Zhiming Liu (216751)

    Published 2025
    “…ROI size: 1.5x10<sup>4</sup> μm<sup>2</sup>. Asterisks denote levels of significance: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, and ns (not statistically significant) signifies p > 0.05. …”
  18. 1018

    Data Sheet 2_The effects of oral medroxyprogesterone acetate combined with conjugated equine estrogens on inflammation in postmenopausal women: a systematic review and meta-analysi... by Jiahui Qiu (7420130)

    Published 2025
    “…</p>Results<p>MPA/CEE treatment was associated with a significant decrease in CRP levels (WMD = -0.173 mg/dL; 95% CI: -0.25 to -0.10; P < 0.001), particularly among postmenopausal women aged <60 years, trials with MPA doses ≤2.5 mg/day, and those with BMI <25 kg/m². …”
  19. 1019

    Data Sheet 1_The effects of oral medroxyprogesterone acetate combined with conjugated equine estrogens on inflammation in postmenopausal women: a systematic review and meta-analysi... by Jiahui Qiu (7420130)

    Published 2025
    “…</p>Results<p>MPA/CEE treatment was associated with a significant decrease in CRP levels (WMD = -0.173 mg/dL; 95% CI: -0.25 to -0.10; P < 0.001), particularly among postmenopausal women aged <60 years, trials with MPA doses ≤2.5 mg/day, and those with BMI <25 kg/m². …”
  20. 1020

    Table 1_The effects of oral medroxyprogesterone acetate combined with conjugated equine estrogens on inflammation in postmenopausal women: a systematic review and meta-analysis of... by Jiahui Qiu (7420130)

    Published 2025
    “…</p>Results<p>MPA/CEE treatment was associated with a significant decrease in CRP levels (WMD = -0.173 mg/dL; 95% CI: -0.25 to -0.10; P < 0.001), particularly among postmenopausal women aged <60 years, trials with MPA doses ≤2.5 mg/day, and those with BMI <25 kg/m². …”